Free Trial

Agilon Health, Inc. (NYSE:AGL) Given Consensus Rating of "Hold" by Analysts

Agilon Health logo with Medical background

Key Points

  • Agilon Health, Inc. (NYSE: AGL) has received a consensus rating of "Hold" from analysts, with two sell ratings, eleven hold ratings, and five buy ratings reported.
  • The company's most recent quarterly earnings revealed a loss of ($0.25) EPS, missing expectations, with revenue falling 5.9% year-over-year.
  • Agilon Health's share price has fluctuated between a twelve-month low of $0.71 and a high of $6.30, with the stock currently trading at about $0.89.
  • Want stock alerts on Agilon Health? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Shares of Agilon Health, Inc. (NYSE:AGL - Get Free Report) have received a consensus rating of "Hold" from the eighteen research firms that are presently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell rating, eleven have issued a hold rating and five have given a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $4.0714.

AGL has been the subject of a number of recent analyst reports. Evercore ISI lowered their price target on Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Cowen reissued a "hold" rating on shares of Agilon Health in a research note on Tuesday, April 15th. Benchmark cut their price objective on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research report on Wednesday. TD Cowen increased their target price on Agilon Health from $3.50 to $6.00 and gave the stock a "hold" rating in a research report on Tuesday, April 15th. Finally, Robert W. Baird lowered their target price on Agilon Health from $6.00 to $5.00 and set a "neutral" rating for the company in a research note on Tuesday, April 15th.

Get Our Latest Research Report on AGL

Agilon Health Stock Up 1.4%

Agilon Health stock opened at $0.89 on Thursday. The firm has a fifty day simple moving average of $2.13 and a two-hundred day simple moving average of $3.18. Agilon Health has a twelve month low of $0.71 and a twelve month high of $6.30. The company has a market capitalization of $369.66 million, a PE ratio of -1.16 and a beta of 0.14.

Agilon Health (NYSE:AGL - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). The company had revenue of $1.39 billion during the quarter, compared to analysts' expectations of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%. Agilon Health's revenue for the quarter was down 5.9% on a year-over-year basis. During the same period last year, the firm earned ($0.07) earnings per share. As a group, equities analysts expect that Agilon Health will post -0.59 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Agilon Health

Several institutional investors and hedge funds have recently made changes to their positions in AGL. SG Americas Securities LLC boosted its stake in Agilon Health by 1,271.3% during the 1st quarter. SG Americas Securities LLC now owns 144,189 shares of the company's stock valued at $624,000 after purchasing an additional 133,674 shares during the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in shares of Agilon Health by 21.8% during the first quarter. Wealth Enhancement Advisory Services LLC now owns 99,697 shares of the company's stock valued at $432,000 after purchasing an additional 17,866 shares during the last quarter. Nisa Investment Advisors LLC grew its position in Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company's stock worth $41,000 after purchasing an additional 6,783 shares during the period. Price T Rowe Associates Inc. MD raised its stake in Agilon Health by 41.0% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 338,529 shares of the company's stock valued at $644,000 after buying an additional 98,377 shares during the last quarter. Finally, Cerity Partners LLC bought a new position in shares of Agilon Health during the 4th quarter valued at $34,000.

Agilon Health Company Profile

(Get Free Report)

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

Featured Stories

Analyst Recommendations for Agilon Health (NYSE:AGL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilon Health Right Now?

Before you consider Agilon Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.

While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Overlooked AI Stocks That Chipmakers Can’t Live Without
Palantir & AMD Earnings: Massive Options Setups Ahead
3 Value Plays Set to Explode

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines